EUVIMEDOpdag EUVIMED
Crossref

Prospective pilot study evaluating a vitamin D3 loading dose in critically ill children with vitamin D deficiency

Elizabeth W Covington iD, Shaneese L Jasper-Trotter, Robert D Arnold, Raj Amin, Susan Egbert, Allison Chung

Fundamental & Clinical Pharmacology · 2024

DOI: 10.1111/fcp.12973 ↗

At a glance

Journal article in Fundamental & Clinical Pharmacology, 2024. Written by Elizabeth W Covington and 5 co-authors. Institution: Harrison College of Pharmacy, Auburn University, Auburn, Alabama, USA. Major MEDLINE topics: Vitamin D Deficiency, Critical Illness, Cholecalciferol, Dietary Supplements. 32 references. Funded by: American College of Clinical Pharmacy, American Foundation for Pharmaceutical Education.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Vitamin D deficiency is a common finding in critically ill children. However, the optimal supplementation strategy in this patient population is unknown. The objective of this study was to evaluate the effects of high‐dose (10 000 IU/kg, max. 400 000 IU) vitamin D supplementation on 25‐hydroxyvitamin D3 (25[OH]D3) levels in pediatric intensive care unit (PICU) patients with baseline vitamin D deficiency.

Methods

This was a prospective, institutional review board‐approved pilot research study performed at the University of South Alabama Women's and Children's Hospital in Mobile, AL. The study sample consisted of patients less than 18 years old admitted to the PICU with baseline 25‐hydroxyvitamin D (25[OH]D) level less than 30 ng/ml. Included patients received a one‐time dose of vitamin D3 orally or via gastric tube (10 000 IU/kg, max. 400 000 IU).

Results

A total of 17 patients were screened with 11 included in the study. Blood analysis revealed a significant increase in 25(OH)D3 level from baseline to 12‐h post dose (21.6 [4.5] ng/ml vs. 46.7 [15.5] ng/ml, P < 0.001). At the 12‐h post‐dose time point, 10/11 patients (91%) had 25(OH)D3 levels that were greater than 30 ng/ml. No adverse effects were observed.

Conclusion

Vitamin D3 supplementation at a dose of 10 000 IU/kg (max. 400 000 IU) significantly increased 25(OH)D3 levels in critically ill pediatric patients.

Subjects

MeSH terms (MEDLINE)

Vitamin D DeficiencyCritical IllnessCholecalciferolDietary SupplementsIntensive Care Units, PediatricHumansPilot ProjectsProspective StudiesFemaleMaleChildChild, PreschoolInfantVitamin DAdolescentDose-Response Relationship, DrugVitamins

Author keywords

cholecalciferolcritical illnesspediatricsvitamin Dvitamin D deficiency

Substances

CholecalciferolVitamin D25-hydroxyvitamin DVitamins

Authors and institutions

  • Harrison College of Pharmacy, Auburn University, Auburn, Alabama, USA.
  • University of Manitoba, Winnipeg, Manitoba, Canada.

ORCID profiles: Elizabeth W Covington

Funding

  • American College of Clinical Pharmacy
  • American Foundation for Pharmaceutical Education

Cite

APA

Covington, E. W., Jasper-Trotter, S. L., Arnold, R. D., Amin, R., Egbert, S., & Chung, A. (2024). Prospective pilot study evaluating a vitamin D3 loading dose in critically ill children with vitamin D deficiency. Fundamental & Clinical Pharmacology. https://doi.org/10.1111/fcp.12973

Vancouver

Covington EW, Jasper-Trotter SL, Arnold RD, Amin R, Egbert S, Chung A. Prospective pilot study evaluating a vitamin D3 loading dose in critically ill children with vitamin D deficiency. Fundamental & Clinical Pharmacology. 2024. doi:10.1111/fcp.12973

BibTeX
@article{Covington2024,
  author = {Covington, Elizabeth W and Jasper-Trotter, Shaneese L and Arnold, Robert D and Amin, Raj and Egbert, Susan and Chung, Allison},
  title = {Prospective pilot study evaluating a vitamin D3 loading dose in critically ill children with vitamin D deficiency},
  journal = {Fundamental & Clinical Pharmacology},
  year = {2024},
  doi = {10.1111/fcp.12973}
}
Start for free →